Lumexa Imaging (NASDAQ:LMRI) Trading Up 7.8% – Still a Buy?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares were up 7.8% during mid-day trading on Thursday . The company traded as high as $12.60 and last traded at $12.49. 726,596 shares were traded during mid-day trading, a decline of 16% from the average daily volume of 866,732 shares. The stock had previously closed at $11.59.

Analyst Ratings Changes

Several equities analysts have commented on LMRI shares. Barclays lowered their target price on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 20th. Weiss Ratings upgraded shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. Finally, Wall Street Zen upgraded shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, Lumexa Imaging has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Lumexa Imaging Stock Performance

The company has a 50 day moving average of $9.17. The firm has a market capitalization of $1.19 billion and a P/E ratio of -21.07. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43.

Insider Buying and Selling

In other Lumexa Imaging news, Director Brett Brodnax bought 35,000 shares of Lumexa Imaging stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the acquisition, the director owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. This represents a 129.50% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Lumexa Imaging

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Monashee Investment Management LLC bought a new stake in shares of Lumexa Imaging during the 4th quarter worth $2,775,000. Seven Grand Managers LLC acquired a new stake in shares of Lumexa Imaging during the fourth quarter worth $11,942,000. Element Capital Management LLC purchased a new stake in shares of Lumexa Imaging during the fourth quarter valued at $1,616,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Lumexa Imaging during the fourth quarter valued at $27,750,000. Finally, Assetmark Inc. acquired a new position in shares of Lumexa Imaging in the 4th quarter valued at $36,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).